FDFT1 anticorps (AA 140-170)
Aperçu rapide pour FDFT1 anticorps (AA 140-170) (ABIN7870661)
Antigène
Voir toutes FDFT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 140-170
-
Fonction
- Squalene synthase Antibody / SQS / FDFT1
-
Purification
- Purified
-
Immunogène
- A portion of amino acids 140-170 from the human protein was used as the immunogen for the Squalene synthase antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- The stated application concentrations are suggested starting points. Titration of the Squalene synthase antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Squalene synthase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- FDFT1 (Farnesyl-Diphosphate Farnesyltransferase 1 (FDFT1))
-
Autre désignation
- Squalene synthase
-
Sujet
- FDFT1 / Squalene synthase catalyzes the first step in the cholesterol biosynthetic pathway, the conversion of trans-farnesyldiphosphate to squalene. The loss of promoter activity and response to sterols for FDFT1 is localized to a 69-bp section positioned 131 bp 5-prime to the transcription start site. Sequence analysis of this region shows that it contains a sterol regulatory element-1 (SRE1) previously identified in other sterol regulated genes and 2 putative NF1 binding sites.
-
UniProt
- P37268
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-